Correction to: Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With Sorafenib

Clin Transl Gastroenterol. 2021 Apr 27;12(5):e00335. doi: 10.14309/ctg.0000000000000335.

Vito Sansone^{1

2}, Francesco Tovoli^{1

2}, Andrea Casadei-Gardini^{3

4

5

6}, Giovan Giuseppe Di Costanzo⁷, Giulia Magini⁸, Rodolfo Sacco^{9

10}, Tiziana Pressiani¹¹, Franco Trevisani^{2

12}, Margherita Rimini¹³, Raffaella Tortora⁷, Elena Nardi^{1

2}, Luca Ielasi^{1

2}, Fabio Piscaglia^{1

2}, Alessandro Granito^{1

2}

¹ Division of Internal Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italia.
² Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
³ Department of Medical Oncology, Università Vita-Salute, San Raffaele Hospital IRCCS, Milan, Italy.
⁴ Dipartimento di Oncologia, IRCCS Ospedale San Raffaele, Milan, Italy.
⁵ School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
⁶ Unit of Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
⁷ Liver Unit, Department of Transplantation, Cardarelli Hospital, Naples, Italy.
⁸ Department of Gastroenterology and Transplant Hepatology, Papa Giovanni XXIII Hospital, Bergamo, Italy.
⁹ Gastroenterology Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
¹⁰ Gastroenterology and Digestive Endoscopy Unit, Foggia University Hospital, Foggia, Italy.
¹¹ Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano (Milan), Italy.
¹² Semeiotica Medica, Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italia.
¹³ Division of Oncology, Department of Oncology and Hematology, University of Modena and Reggio Emilia, Modena, Italy.

No abstract available

Publication types